UPDATE 1-Tempus to buy cancer test maker Personalis for $1.5 billion

(Adds share move in paragraph 2, deal details throughout) July 20 (Reuters) – Tempus AI said on Monday it would buy Personalis in an all-stock deal valued at about $1.5 billion, adding a cancer test

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)